J8655 Netupitant 300 mg and palonosetron 0.5 mg, oral

Short descriptor: Oral netupitant, palonosetro

✓ Active HCPCS Level II 2026
Open J8655 in the app →

Look up J8655 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J8655 is the HCPCS Level II code for Netupitant 300 mg and palonosetron 0.5 mg, oral (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2019-01-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
Netupitant 300 mg and palonosetron 0.5 mg
Route
oral

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J8655 with the canonical source and edition:

J8655 — Netupitant 300 mg and palonosetron 0.5 mg, oral. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J8655

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J8655

Related Codes in Section J

← J8650 Nabilone oral J8670 → Rolapitant, oral, 1mg
J8610 Methotrexate oral 2.5 mg J8611 Oral methotrexate (jylamvo) J8612 Oral methotrexate (xatmep) J8650 Nabilone oral J8670 Rolapitant, oral, 1mg J8700 Temozolomide J8705 Topotecan oral J8999 Oral prescription drug chemo J9000 Doxorubicin hcl injection J9010 Alemtuzumab injection
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial